AVDL Option Call 20-12-2024 35 Option on Avadel Pharmaceuticals
AVDL Stock | USD 10.00 0.15 1.48% |
AVDL Option Call 20-12-2024 35 is a CALL option contract on Avadel Pharmaceuticals' common stock with a strick price of 35.0 expiring on 2024-12-20. The contract was last traded on 2024-04-19 at 15:35:35 for $0.3 and, as of today, has 9 days remaining before the expiration. The option is currently trading at an ask price of $1.0. The implied volatility as of the 11th of December 2024 is 9.0.
Avadel |
Call options on Avadel Pharmaceuticals give the investor right to buy Avadel Stock at a specified price within a specific period. If Avadel Pharmaceuticals' price is above the strike price at expiry, the profit is the current Avadel Pharmaceuticals' stock price, minus the strike price and the premium.
Rule 16 of 2024-12-20 Option Contract
The options market is anticipating that Avadel Pharmaceuticals PLC will have an average daily up or down price movement of about 0.33% per day over the life of the option. With Avadel Pharmaceuticals trading at USD 10.0, that is roughly USD 0.0327. If you think that the market is fully understating Avadel Pharmaceuticals' daily price movement you should consider buying Avadel Pharmaceuticals PLC options at that current volatility level of 5.23%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Out Of The Money Call Option on Avadel Pharmaceuticals
An 'Out of The Money' option on Avadel has a strike price that Avadel Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Avadel Pharmaceuticals' 'Out of The Money' options include buying the options if you expect a big move in Avadel Pharmaceuticals' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Call Contract Name | AVDL Option Call 20-12-2024 35 |
Expires On | 2024-12-20 |
Days Before Expriration | 9 |
Last Traded On | 2024-04-19 15:35:35 |
Open Interest | 19 |
Current Trading Volume | 19.0 |
Strike Price | 35.0 |
Last Traded At | 0.3 |
Current Price Spread | 0.0 | 1.0 |
Rule 16 Daily Up or Down | USD 0.0327 |
Avadel long CALL Option Payoff at expiration
Buying Avadel Pharmaceuticals' call option is the simplest of option trades. A call option on Avadel Stock gives investors the right (but not the obligation) to purchase Avadel Pharmaceuticals at the given strike price. Therefore Avadel Pharmaceuticals' call intrinsic value or payoff at expiration depends on where the Avadel Stock price is relative to the call option strike price. The strike price of 35.0 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and negative (the trade is a loss). Above the strike, the payoff line is upward sloping as the option payoff rises in proportion with Avadel Pharmaceuticals' price. Finally, at the break-even point of 35.0, the line crosses zero, and trading Avadel becomes profitable.
Profit |
Avadel Pharmaceuticals Price At Expiration |
Avadel short CALL Option Payoff at expiration
By selling Avadel Pharmaceuticals' call option, the investors signals his or her bearish sentiment. A short position in a call option written on Avadel Pharmaceuticals will generally make money when the underlying price goes down. Therefore Avadel Pharmaceuticals' call intrinsic value or payoff at expiration depends on where the Avadel Stock price is relative to the call option strike price. The strike price of 35.0 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and positive (the seller makes a profit). Above the strike, the payoff line is downward sloping as the option payoff drops in proportion to Avadel Pharmaceuticals' price. Finally, at the break-even point of 35.0, the line crosses zero, and trading Avadel becomes disadvantageous with no downside limits.
Profit |
Avadel Pharmaceuticals Price At Expiration |
Avadel Pharmaceuticals Available Call Options
Avadel Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Avadel. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Avadel. It also shows strike prices and maturity days for a Avadel Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open Int | Expiration | Current Spread | Last Price | |||
Call | AVDL Option Call 20-12-2024 7 | 0 | 2024-12-20 | 0.0 - 0.0 | 3.58 | In |
Call | AVDL Option Call 20-12-2024 10 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.32 | |
Call | AVDL Option Call 20-12-2024 12 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.05 | |
Call | AVDL Option Call 20-12-2024 15 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.05 | |
Call | AVDL Option Call 20-12-2024 17 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.1 | |
Call | AVDL Option Call 20-12-2024 20 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.05 | |
Call | AVDL Option Call 20-12-2024 22 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.08 | |
Call | AVDL Option Call 20-12-2024 25 | 69 | 2024-12-20 | 0.0 - 0.35 | 0.4 | Out |
Call | AVDL Option Call 20-12-2024 30 | 3 | 2024-12-20 | 0.0 - 0.75 | 0.3 | Out |
Call | AVDL Option Call 20-12-2024 35 | 19 | 2024-12-20 | 0.0 - 1.0 | 0.3 | Out |
Avadel Pharmaceuticals Corporate Management
Gregory Davis | VP Development | Profile | |
Richard Kim | Chief Officer | Profile | |
Christian PharmD | Chief Affairs | Profile | |
Steven Sullivan | VP Operations | Profile | |
Jason Vaughn | Senior Operations | Profile | |
Jennifer PharmD | Senior Affairs | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share 1.036 | Quarterly Revenue Growth 26.743 | Return On Assets (0.34) | Return On Equity (1.00) |
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.